The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organics Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Virupaksha Organics Ltd, the promoter of Oxygenta Pharmaceutical Ltd, bought 1,95,885 equity shares (0.53% stake) through open market purchase on 15 December 2025. Before the purchase, the promoter held 2,04,77,458 shares (55.37%); after the purchase, the holding rose to 2,06,73,343 shares (55.90%). The total share capital remains 3,69,83,500 equity shares of Rs. 10 each. The disclosure was filed under Regulation 29(2) of SEBI Takeover Regulations, 2011.
This is a small open-market purchase by the promoter, marginally increasing its already controlling stake from 55.37% to 55.90%. It signals continued promoter confidence but is too small to materially affect share price or control dynamics.